Literature DB >> 33918332

Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7.

Marek Widera1, Barbara Mühlemann2, Victor M Corman2, Tuna Toptan1, Jörn Beheim-Schwarzbach2, Niko Kohmer1, Julia Schneider2, Annemarie Berger1, Talitha Veith2, Christiane Pallas1, Tobias Bleicker2, Udo Goetsch3, Julia Tesch2, Rene Gottschalk3, Terry C Jones2,4, Sandra Ciesek1,5,6, Christian Drosten2,5.   

Abstract

BACKGROUND: International travel is a major driver of the introduction and spread of SARS-CoV-2. AIM: To investigate SARS-CoV-2 genetic diversity in the region of a major transport hub in Germany, we characterized the viral sequence diversity of the SARS-CoV-2 variants circulating in Frankfurt am Main, the city with the largest airport in Germany, from the end of October to the end of December 2020.
METHODS: In total, we recovered 136 SARS-CoV-2 genomes from nasopharyngeal swab samples. We isolated 104 isolates that were grown in cell culture and RNA from the recovered viruses and subjected them to full-genome sequence analysis. In addition, 32 nasopharyngeal swab samples were directly sequenced. RESULTS AND
CONCLUSION: We found 28 different lineages of SARS-CoV-2 circulating during the study period, including the variant of concern B.1.1.7 (Δ69/70, N501Y). Six of the lineages had not previously been observed in Germany. We detected the spike protein (S) deletion Δ69/Δ70 in 15% of all sequences, a four base pair (bp) deletion (in 2.9% of sequences) and a single bp deletion (in 0.7% of sequences) in ORF3a, leading to ORF3a truncations. In four sequences (2.9%), an amino acid deletion at position 210 in S was identified. In a single sample (0.7%), both a 9 bp deletion in ORF1ab and a 7 bp deletion in ORF7a were identified. One sequence in lineage B.1.1.70 had an N501Y substitution while lacking the Δ69/70 in S. The high diversity of sequences observed over two months in Frankfurt am Main highlights the persisting need for continuous SARS-CoV-2 surveillance using full-genome sequencing, particularly in cities with international airport connections.

Entities:  

Keywords:  B.1.1.7; N501Y; SARS-CoV-2; genetic diversity; molecular surveillance; natural selection; spike mutation

Year:  2021        PMID: 33918332     DOI: 10.3390/microorganisms9040748

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  4 in total

1.  Comparative genomics, evolutionary epidemiology, and RBD-hACE2 receptor binding pattern in B.1.1.7 (Alpha) and B.1.617.2 (Delta) related to their pandemic response in UK and India.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Bidyut Mallik; Shyam Sundar Nandi; Sang-Soo Lee
Journal:  Infect Genet Evol       Date:  2022-04-13       Impact factor: 4.393

Review 2.  Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines.

Authors:  Narasimha M Beeraka; Olga A Sukocheva; Elena Lukina; Junqi Liu; Ruitai Fan
Journal:  Rev Med Virol       Date:  2022-04-13       Impact factor: 11.043

3.  Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics.

Authors:  Andrei Veleanu; Maximilian A Kelch; Chengjin Ye; Melanie Flohr; Alexander Wilhelm; Marek Widera; Luis Martinez-Sobrido; Sandra Ciesek; Tuna Toptan
Journal:  Viruses       Date:  2022-09-12       Impact factor: 5.818

4.  Estimating infectiousness throughout SARS-CoV-2 infection course.

Authors:  Terry C Jones; Guido Biele; Barbara Mühlemann; Talitha Veith; Julia Schneider; Jörn Beheim-Schwarzbach; Tobias Bleicker; Julia Tesch; Marie Luisa Schmidt; Leif Erik Sander; Florian Kurth; Peter Menzel; Rolf Schwarzer; Marta Zuchowski; Jörg Hofmann; Andi Krumbholz; Angela Stein; Anke Edelmann; Victor Max Corman; Christian Drosten
Journal:  Science       Date:  2021-05-25       Impact factor: 63.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.